GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $752,000 | +0.1% | 17,292 | +0.2% | 0.35% | +21.5% |
| Q1 2022 | $751,000 | +16.4% | 17,260 | +17.9% | 0.29% | +15.1% |
| Q4 2021 | $645,000 | +14.4% | 14,640 | -0.9% | 0.25% | +5.5% |
| Q3 2021 | $564,000 | -0.5% | 14,766 | +3.5% | 0.24% | -0.4% |
| Q2 2021 | $567,000 | +43.2% | 14,263 | +28.3% | 0.24% | +25.8% |
| Q1 2021 | $396,000 | +26.9% | 11,115 | +30.8% | 0.19% | +19.5% |
| Q4 2020 | $312,000 | +2.0% | 8,499 | +4.2% | 0.16% | -9.1% |
| Q3 2020 | $306,000 | -14.8% | 8,155 | -7.4% | 0.18% | -22.6% |
| Q2 2020 | $359,000 | +9.8% | 8,808 | +1.9% | 0.23% | -2.6% |
| Q1 2020 | $327,000 | +5.1% | 8,646 | +30.3% | 0.23% | +34.9% |
| Q4 2019 | $311,000 | +25.9% | 6,638 | +15.8% | 0.17% | +13.2% |
| Q3 2019 | $247,000 | +6.5% | 5,733 | 0.0% | 0.15% | +5.6% |
| Q2 2019 | $232,000 | -0.9% | 5,733 | +2.2% | 0.14% | -5.3% |
| Q1 2019 | $234,000 | +16.4% | 5,609 | +13.7% | 0.15% | -2.6% |
| Q2 2018 | $201,000 | – | 4,933 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |